Clinical trial
Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis
NCT00035958 · Children's Hospital Medical Center, Cincinnati, Other · Terminated
Key facts
| NCT number | NCT00035958 |
|---|---|
| Title | Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis |
| Official title | Toward Improved Understanding of Pathogenesis and Treatment of Childhood Onset Dermatomyositis |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH Immunex Corporation Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Dermatomyositis |
| Intervention type | Drug |
| Interventions | Prednisone, Methotrexate, Etanercept |
| Enrollment | 75 |
| Start date | Aug 1, 2002 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | May 8, 2002 |
| Last update posted | Aug 1, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: